Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

12,799

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

12,799 results for “Immunization”

Learn how ShareScore rates datasets ↗
zenodo20/100

Spatial Immune Associations of Immunotherapy Response in Non-Small Cell Lung Cancer by Multiplexed Tissue Imaging

Open the record for dataset details and reuse information.

opencc-by-4.0Dec 2023View details →
zenodo20/100

THE ROLE OF INTESTINAL MICROFLORA AND PROBIOTICS IN THE DEVELOPMENT OF IMMUNITY IN INFANTS

Open the record for dataset details and reuse information.

opencc-by-4.0Dec 2023View details →
zenodo20/100

raw data related to project "Circulating biomarkers as predictors of gender-specific response to Immune Checkpoint Inhibitors in melanoma and non-small-cell lung cancer patients"

<p><strong>Sex-related differences in serum biomarker levels predict the activity and efficacy of Immune Checkpoint Inhibitors in advanced melanoma and Non-Small Cell Lung Cancer patients.</strong></p> <p><strong>Abstract&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></p> <p><strong>Background:</strong> Immune Checkpoint Inhibitors (ICIs) lead to durable response and a significant increase in long-term survival in patients with advanced malignant melanoma (MM) and Non-Small Cell Lung Cancer (NSCLC). The identification of serum cytokines that can predict their activity and efficacy, and their sex interaction, could improve treatment personalization.&nbsp;</p> <p><strong>Methods: </strong>In this prospective study, we enrolled immunotherapy-na&iuml;ve patients affected by advanced MM and NSCLC treated with ICIs. The primary endpoint was to dissect the potential sex correlations between serum cytokines (IL-1&beta;, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, GM-CSF, MCP-1, TNF-ɑ, IP-10, VEGF, sPD-L1) and the overall response rate (ORR). Secondly, we analyzed biomarker changes during treatment related to ORR, disease control rate (DCR), progression free survival (PFS) and overall survival (OS). Blood samples, collected at baseline and during treatment until disease progression (PD) or up to 2 years, were analyzed using Luminex xMAP or ELLA based technology.&nbsp;</p> <p>Three Luminex xMAP assays and two ELLA microfluidic cartridges were used to screen 28 immune-related biomarkers in 38 paired serum and citrate-theophylline-adenosine-dipyridamole (CTAD) plasma samples collected from 10 advanced melanoma or non-small cell lung cancer (NSCLC) patients at different time points during immunotherapy.</p> <p><strong>Results</strong>: Serum samples from 161 patients (98 males/63 females; 92 MM/69 NSCLC) were analyzed for treatment response. At baseline, IL-6 was significantly lower in females (F) <em>versus</em> males (M); lower levels of IL-4 in F and of IL-6 in both sexes significantly correlated with a better ORR, while higher IL-4 and TNF-ɑ values were predictive of a lower probability of ORR in F <em>versus</em> M. One hundred and sixty-five patients were evaluable for survival analysis: at multiple Cox regression, an increased risk of PD was observed in F with higher baseline values of IL-4, sPD-L1 and IL-10, while higher IL-6 was a negative predictor in males. In males, higher levels of GM-CSF predict a longer survival, whereas higher IL-1&beta; predicts a shorter survival. Regardless of sex, high baseline IL-8 values were associated with an increased risk of both PD and death, and high IL-6 levels only with shorter OS.&nbsp;</p> <p>Twenty-three of 28 biomarkers were detected both in serum and plasma by at least one of the assays, including IL-1&beta;, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, GM-CSF, IFN-&gamma;, TNF-&alpha;, VEGF, IP-10, MCP-1, eotaxin, fractalkine, G-CSF, IFN-&alpha;, IL-1RA, IL-13, IL-17A, MIP-1&beta; and sPD-L1. Conversely, FGF-2 and IL-1&alpha; were not detected in both matrices; GRO-&alpha; factor and EGF were detected only in serum and MIP-1&alpha; only in plasma. sPD-L1, MCP-1, IFN-&gamma;, IL-8, MIP-1&beta; and VEGF were, respectively, 1.15-, 1.44-, 1.83-, 2.43-, 2.82-, 6.72-fold higher in serum, whereas IL-10, IL-4, IL-2 and IL-5 were 1.05-, 1.19-, 1.92- and 2.17-fold higher, respectively, in plasma. IP-10 levels were higher in plasma but, as well as for VEGF, the bias serum versus plasma varied depending on the assay used (IP-10: &minus;5.7% to &minus;145%; VEGF: 115% to 165%). No significant differences were found for the remaining nine analyzed cytokines.</p> <p><strong>Conclusions</strong></p> <p>Serum IL-1&beta;, IL-4, IL-6, IL-10, GM-CSF, TNFɑ, and sPDL1 had a significant independent sex-related predictive impact on ORR, PFS and OS in melanoma and NSCLC patients treated with ICIs. These results will potentially pave the way for new ICI combinations, designed according to baseline and early changes of these cytokines and stratified by sex.&nbsp;</p> <p>The cytokine and sPD-L1 levels may differ between serum and plasma samples collected from cancer patients treated with immunotherapy, and the results obtained can be influenced by the different characteristics of the tested assays.</p>

restrictedcc-by-4.0Nov 2023View details →
zenodo20/100

Supplementary tables for Predictive role of ferroptosis long non-coding RNAs for immune microenvironment and microsatellite instability in colon cancer

<p>These are supplementary tables.</p>

opencc-by-4.0Oct 2021View details →
zenodo20/100

Epigenetic programming by H3K23ac defines lineage fate of Meg3+ hematopoietic stem cells and drives immune aging (Supplemental Table)

Open the record for dataset details and reuse information.

restrictedcc-by-4.0Jun 2024View details →
zenodo20/100

Mapping spatial organization and genetic cell state regulators to target immune evasion in ovarian cancer

<p>This collection of data accompanies the study: <a href="https://www.nature.com/articles/s41590-024-01943-5">Yeh, Aguirre, Laveroni&nbsp;<em>et al.</em> <strong>Mapping spatial organization and genetic cell-state regulators to target immune evasion in ovarian cancer.&nbsp;</strong>(2024). </a><em><strong><a href="https://www.nature.com/articles/s41590-024-01943-5">Nature Immunology</a>.</strong></em>&nbsp; Files are provided in the form of RObjects (extension .rds) or tabulated data (extension .csv) to reproduce the results and figures provided in the paper via the the R programming environment using Code provided <a href="https://github.com/Jerby-Lab/HGSC_SpatialPerturbational">here</a>.&nbsp;</p> <p>&nbsp;</p> <p>Data collected and processed and published as a part of this study of tubo-ovarian high grade serous carcinoma (HGSC) includes:&nbsp;</p> <ul> <li>~<strong>2.5 million single cell spatial transcriptomics profiles</strong> from <strong>130 HGSC tumors</strong> of <strong>94 patients</strong></li> <li>Matching de-identified <strong>clinical annotations</strong> and clinical outcomes.</li> <li>Matching <strong>targeted genomic data</strong> from the bulk tumor tissues.</li> <li><strong>Perturb-seq CRISPR knockout</strong> data in ovarian cancer cells in monoculture and co-culture with Natural Killer (NK) cells.</li> </ul> <p>The spatial transcriptomics, Perturb-Seq, and matched H&amp;E (Hematoxylin &amp; Eosin, where available) are also provided via the Single Cell Portal with an <strong>interactive interface</strong> (<a href="https://singlecell.broadinstitute.org/single_cell/study/SCP2640/hgsc-spatial-cohort-discovery-dataset">SCP2640</a>, <a href="https://singlecell.broadinstitute.org/single_cell/study/SCP2641/hgsc-spatial-cohort-validation-1-dataset">SCP2641</a>, <a href="https://singlecell.broadinstitute.org/single_cell/study/SCP2650/hgsc-spatial-cohort-validation-2-dataset">SCP2650</a>, <a href="https://singlecell.broadinstitute.org/single_cell/study/SCP2644/hgsc-spatial-cohort-test-1-dataset">SCP2644</a>, <a href="https://singlecell.broadinstitute.org/single_cell/study/SCP2646/hgsc-spatial-cohort-test-2-dataset">SCP2646</a>, <a href="https://singlecell.broadinstitute.org/single_cell/study/SCP2707/hgsc-spatial-study-perturb-seq">SCP2707</a>).</p> <p>The collection also includes previously published data that was analyzed and used in this study to examine the generalizability of the findings, evaluate immunotherapy predictors, and for data-driven experimental design.</p> <p>The SeuratObj.zip contains six SeuratObjects matching the five spatial transcriptomcs datasets (Discovery, Validation 1, Validation 2, Test 1 and Test 2) and Perturb-Seq data.</p> <p>The Yeh2024.zip file includes the study's data and additional datasets/results to reproduce the study's figures.&nbsp;A detailed description of the files included in the repository is provided in `README.txt` and `README.xlsx`</p>

openJul 2024View details →
zenodo20/100

Microglia from patients with multiple sclerosis display cell-autonomous immune activation state

<p>This repository contains the data and the code used in tanja hyvarinen's project (tanja.hyvarinen@tuni.fi)</p> <p>"analysis" contains the processing and analysis of the bulk RNA sequencing data, contains the analysis of the integration between our RNA seq and external datasets.<br>"fastq" contains the raw fastq sequences of the bulk RNA sequencing<br>"counts" contains the results of processing the fasta sequences with nfcore rnaseq workflow&nbsp;</p> <p>Analysis and integration folders can contain the starting raw data in "data", the R scripts in order of execution (op1, op2 ..) and the "output" folder that contains the final processed data of each operation.</p>

restrictedcc-by-4.0Nov 2024View details →
ClinicalTrials.gov20/100

Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 Weeks

ClinicalTrials.gov study NCT02257645. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov20/100

Pilot Study on Effect Size of Non-digestible Polysaccharides (NPS) on Immunity

ClinicalTrials.gov study NCT01896154. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov20/100

Immune Response and Risk of Side Effects After Influenza Vaccination in Athletes

ClinicalTrials.gov study NCT03654937. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov20/100

Immunonutrition Effects on Nutrition and Immunity in HNC During Radiotherapy

ClinicalTrials.gov study NCT07017218. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov20/100

Effect of Soluble Fiber on Hypertriglyceridemia and Immune Profile in HIV-positive Individuals.

ClinicalTrials.gov study NCT00540111. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov20/100

Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South Africa

ClinicalTrials.gov study NCT01927835. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov20/100

Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia

ClinicalTrials.gov study NCT07206758. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov20/100

Study Evaluating the Safety and Ability to Produce Immune Response of Prevenar and Meningitec Given at the Same Time

ClinicalTrials.gov study NCT00581035. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov20/100

Ivarmacitinib in Advanced Solid Tumors: A Prospective, Two-Cohort, Two-Phase Exploratory Study in Patients Discontinued Due to Immune Intolerance

ClinicalTrials.gov study NCT07313202. IPD Sharing: NO. Countries: 0. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov20/100

Rabies Immunization Concomitant With JEV in Children

ClinicalTrials.gov study NCT00703521. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov20/100

Post-surgery Systemic Inflammation and Neuro-immune Interactions

ClinicalTrials.gov study NCT03055325. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov20/100

Immune Function of Colorectal Cancer Lymph Nodes

ClinicalTrials.gov study NCT06319404. IPD Sharing: NO. Countries: 0. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov20/100

Immune Adverse Events Registry in Onco-Hematologic Patients Treated With Immunotherapy

ClinicalTrials.gov study NCT07198958. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.